The polypill for cardiovascular disease : why is it used so infrequently?
Cardiovascular polypills or fixed-dose combination (FDC) therapy have been advocated to improve treatment and prevention of cardiovascular disease since 2003. Yet, it is still used infrequently in current practice. This is in contrast to the widespread use of fixed-dose drug combinations for HIV, tu...
|Published in:||Nederlands tijdschrift voor geneeskunde, Vol. 162 (2018)|
|Other Involved Persons:|
|Item Description:||Date Completed 20.09.2019|
Date Revised 20.09.2019
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
|QR Code:||Show QR Code|